ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityNo recent work listed

Lin Miao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0248-2544; OpenAlex author ID A5100324187. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulating Cortactin. Co-author DOI 10.18632/aging.103032 ↗
Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Last author DOI 10.26355/eurrev_201812_16627 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yun Wang · 1 shared paper, 2020 · strength 0.12
- Paper Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulati… DOI 10.18632/aging.103032 ↗
Lihua Yang · 1 shared paper, 2020 · strength 0.12
- Paper Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulati… DOI 10.18632/aging.103032 ↗
X Qiao · 1 shared paper, 2018 · strength 0.09
- Paper Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activati… DOI 10.26355/eurrev_201812_16627 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.